CN133, a Novel Brain-Penetrating Histone Deacetylase Inhibitor, Hampers Tumor Growth in Patient-Derived Pediatric Posterior Fossa Ependymoma Models


Por: Antonelli, R, Jiménez, C, Riley, M, Servidei, T, Riccardi, R, Soriano, A, Roma, J, Martínez-Saez, E, Martini, M, Ruggiero, A, Moreno, L, Sanchez deToledo J, Gallego, S, Bové, J, Hooker, JM and Segura, MF

Publicada: 1 jul 2020
Resumen:
Pediatric ependymoma (EPN) is a highly aggressive tumor of the central nervous system that remains incurable in 40% of cases. In children, the majority of cases develop in the posterior fossa and can be classified into two distinct molecular entities: EPN posterior fossa A (PF-EPN-A) and EPN posterior fossa B (PF-EPN-B). Patients with PF-EPN-A have poor outcome and are in demand of new therapies. In general, PF-EPN-A tumors show a balanced chromosome copy number profile and have no recurrent somatic nucleotide variants. However, these tumors present abundant epigenetic deregulations, thereby suggesting that epigenetic therapies could provide new opportunities for PF-EPN-A patients. In vitro epigenetic drug screening of 11 compounds showed that histone deacetylase inhibitors (HDACi) had the highest anti-proliferative activity in two PF-EPN-A patient-derived cell lines. Further screening of 5 new brain-penetrating HDACi showed that CN133 induced apoptosis in vitro, reduced tumor growth in vivo and significantly extended the survival of mice with orthotopically-implanted EPN tumors by modulation of the unfolded protein response, PI3K/Akt/mTOR signaling, and apoptotic pathways among others. In summary, our results provide solid preclinical evidence for the use of CN133 as a new therapeutic agent against PF-EPN-A tumors.

Filiaciones:
Antonelli, R:
 Univ Autonoma Barcelona UAB, Grp Translat Res Child & Adolescent Canc, Vall dHebron Res Inst VHIR, Barcelona 08035, Spain

Jiménez, C:
 Univ Autonoma Barcelona UAB, Grp Translat Res Child & Adolescent Canc, Vall dHebron Res Inst VHIR, Barcelona 08035, Spain

Riley, M:
 Massachusetts Gen Hosp, Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA

 Harvard Med Sch, Charlestown, MA 02129 USA

Servidei, T:
 Fdn Policlin Univ A Gemelli IRCCS, UOC Oncol Pediat, I-00168 Rome, Italy

Riccardi, R:
 Fdn Policlin Univ A Gemelli IRCCS, UOC Oncol Pediat, I-00168 Rome, Italy

Soriano, A:
 Univ Autonoma Barcelona UAB, Grp Translat Res Child & Adolescent Canc, Vall dHebron Res Inst VHIR, Barcelona 08035, Spain

Roma, J:
 Univ Autonoma Barcelona UAB, Grp Translat Res Child & Adolescent Canc, Vall dHebron Res Inst VHIR, Barcelona 08035, Spain

Martínez-Saez, E:
 Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Dept Pathol, Barcelona 08035, Spain

Martini, M:
 Univ Cattolica Sacro Cuore, Fdn Policlin A Gemelli IRCCS, Dept Pathol, Lgo A Gemelli 8, I-00141 Rome, Italy

Ruggiero, A:
 Fdn Policlin Univ A Gemelli IRCCS, UOC Oncol Pediat, I-00168 Rome, Italy

Moreno, L:
 Univ Autonoma Barcelona UAB, Grp Translat Res Child & Adolescent Canc, Vall dHebron Res Inst VHIR, Barcelona 08035, Spain

 Univ Autonoma Barcelona UAB, Pediat Oncol & Hematol Dept, Hosp Univ Vall dHebron, Passeig Vall dHebron 119, Barcelona 08035, Spain

Sanchez deToledo J:
 Univ Autonoma Barcelona UAB, Grp Translat Res Child & Adolescent Canc, Vall dHebron Res Inst VHIR, Barcelona 08035, Spain

 Univ Autonoma Barcelona UAB, Pediat Oncol & Hematol Dept, Hosp Univ Vall dHebron, Passeig Vall dHebron 119, Barcelona 08035, Spain

Gallego, S:
 Univ Autonoma Barcelona UAB, Grp Translat Res Child & Adolescent Canc, Vall dHebron Res Inst VHIR, Barcelona 08035, Spain

 Univ Autonoma Barcelona UAB, Pediat Oncol & Hematol Dept, Hosp Univ Vall dHebron, Passeig Vall dHebron 119, Barcelona 08035, Spain

Bové, J:
 Ctr Networked Biomed Res Neurodegenerat Dis CIBER, Vall dHebron Res Inst, Neurodegenerat Dis Res Grp, Barcelona 08035, Spain

Hooker, JM:
 Massachusetts Gen Hosp, Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA

 Harvard Med Sch, Charlestown, MA 02129 USA

Segura, MF:
 Univ Autonoma Barcelona UAB, Grp Translat Res Child & Adolescent Canc, Vall dHebron Res Inst VHIR, Barcelona 08035, Spain
ISSN: 20726694





Cancers
Editorial
MDPI, MDPI AG, Grosspeteranlage 5, CH-4052 BASEL, SWITZERLAND, Suiza
Tipo de documento: Article
Volumen: 12 Número: 7
Páginas:
WOS Id: 000558063100001
ID de PubMed: 32708733
imagen gold, Green Published

MÉTRICAS